A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.

@article{Garsa2013APL,
  title={A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.},
  author={Adam A. Garsa and Daniel J. Ferraro and Todd A Dewees and Teresa L. Deshields and Julie Margenthaler and Amy E. Cyr and Michael C Naughton and Rebecca L. Aft and William E. Gillanders and Timothy J. Eberlein and Melissa A Matesa and Laura L Ochoa and Imran Zoberi},
  journal={International journal of radiation oncology, biology, physics},
  year={2013},
  volume={87 5},
  pages={1043-50}
}
PURPOSE To prospectively examine quality of life (QOL) of patients with early stage breast cancer treated with accelerated partial breast irradiation (APBI) using high-dose-rate (HDR) interstitial brachytherapy. METHODS AND MATERIALS Between March 2004 and December 2008, 151 patients with early stage breast cancer were enrolled in a phase 2 prospective clinical trial. Eligible patients included those with Tis-T2 tumors measuring ≤3 cm excised with negative surgical margins and with no nodal… CONTINUE READING